A Recent Update of Three Consecutive Prospective Trials with High-Dose Therapy and Autograft, without or with Rituximab, as Primary Treatment for Advanced-Stage Follicular Lymphoma (FL) Shows a Sizeable Group of Patients Surviving in Continuous Complete Remission up to 16 Years After the End of Treatment: Should We Still Consider FL An Incurable Disease ?
Articolo
Data di Pubblicazione:
2009
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Tarella, C; Ladetto, M; Benedetti, F; Vitolo, U; Pulsoni, A; Patti, C; Callea, V; Rambaldi, A; Piccin, A; Magni, M; Musso, M; Iannitto, E; Spedini, P; Liberati, Am; Ciceri, Fabio; Gallamini, A; Rodeghiero, F; Gini, G; De Crescenzo, A; Di Raimondo, F; Levis, A; Chisesi, T; Perrone, T; Scalabrini, Dr; Rossi, G; Carella, Am; Parvis, G; Majolino, I; Passera, R; Ruella, M; Pileri, A; Gianni, A; Corradini, P.
Link alla scheda completa:
Pubblicato in: